Centre for Medical Oncology, Queen Mary University of London, Barts, United Kingdom.
Blood. 2010 Jun 17;115(24):5053-6. doi: 10.1182/blood-2009-11-253260. Epub 2010 Apr 7.
Follicular lymphoma has considerable clinical heterogeneity, and there is a need for easily quantifiable prognostic biomarkers. Microvessel density has been shown to be a useful prognostic factor based on numerical assessment of vessel numbers within histologic sections in some studies, but assessment of tumor neovascularization through angiogenic sprouting may be more relevant. We therefore examined the smallest vessels, single-staining structures measuring less than 30 microm(2) in area, seen within histologic sections, and confirmed that they were neovascular angiogenic sprouts using extended focal imaging. Tissue microarrays composing diagnostic biopsies from patients at the extremes of survival of follicular lymphoma were analyzed with respect to numbers of these sprouts. This analysis revealed higher angiogenic activity in the poor prognostic group and demonstrated an association between increased sprouting and elevated numbers of infiltrating CD163(+) macrophages within the immediate microenvironment surrounding the neovascular sprout.
滤泡性淋巴瘤具有相当大的临床异质性,因此需要易于量化的预后生物标志物。一些研究显示,基于组织切片中血管数量的数值评估,微血管密度是一种有用的预后因素,但通过血管生成发芽来评估肿瘤新生血管化可能更为相关。因此,我们检查了组织切片中所见的最小血管,即面积小于 30 微米 2 的单染色结构,并通过扩展的焦点成像确认它们是新生血管生成的芽。对滤泡性淋巴瘤患者生存预后极值的诊断性活检组织微阵列进行了分析,以确定这些芽的数量。这项分析显示,在预后不良的组中,血管生成活性更高,并证明了在新生血管芽周围的微环境中浸润的 CD163+巨噬细胞数量增加与发芽增加之间存在关联。